12.2. Drugs acting on the nose
12.2.4. Biologic treatments for use in chronic rhinosinusitis with nasal polyps
Total Formulary
DUPILUMAB (DUPIXENT)
Restrictions:
Restricted to specialist use as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe chronic rhinosinusitis with nasal polyps for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control, and who have had one or more prior surgery for chronic rhinosinusitis with nasal polyps and have a SNOT-22 score of 50 or higher.


